company background image
600511 logo

China National Medicines SHSE:600511 Stock Report

Last Price

CN¥29.57

Market Cap

CN¥22.3b

7D

3.1%

1Y

-9.8%

Updated

09 Sep, 2024

Data

Company Financials +

China National Medicines Corporation Ltd.

SHSE:600511 Stock Report

Market Cap: CN¥22.3b

China National Medicines Corporation Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for China National Medicines
Historical stock prices
Current Share PriceCN¥29.57
52 Week HighCN¥37.80
52 Week LowCN¥26.58
Beta0.40
11 Month Change-12.26%
3 Month Change-13.34%
1 Year Change-9.85%
33 Year Change-3.43%
5 Year Change3.07%
Change since IPO821.66%

Recent News & Updates

Calculating The Fair Value Of China National Medicines Corporation Ltd. (SHSE:600511)

Sep 10
Calculating The Fair Value Of China National Medicines Corporation Ltd. (SHSE:600511)

Returns On Capital At China National Medicines (SHSE:600511) Paint A Concerning Picture

Jul 28
Returns On Capital At China National Medicines (SHSE:600511) Paint A Concerning Picture

Recent updates

Calculating The Fair Value Of China National Medicines Corporation Ltd. (SHSE:600511)

Sep 10
Calculating The Fair Value Of China National Medicines Corporation Ltd. (SHSE:600511)

Returns On Capital At China National Medicines (SHSE:600511) Paint A Concerning Picture

Jul 28
Returns On Capital At China National Medicines (SHSE:600511) Paint A Concerning Picture

China National Medicines Corporation Ltd.'s (SHSE:600511) Low P/E No Reason For Excitement

Jun 24
China National Medicines Corporation Ltd.'s (SHSE:600511) Low P/E No Reason For Excitement

China National Medicines (SHSE:600511) Has Announced That It Will Be Increasing Its Dividend To CN¥0.854

Jun 07
China National Medicines (SHSE:600511) Has Announced That It Will Be Increasing Its Dividend To CN¥0.854

Is China National Medicines (SHSE:600511) Using Too Much Debt?

Jun 05
Is China National Medicines (SHSE:600511) Using Too Much Debt?

Calculating The Fair Value Of China National Medicines Corporation Ltd. (SHSE:600511)

May 21
Calculating The Fair Value Of China National Medicines Corporation Ltd. (SHSE:600511)

Capital Allocation Trends At China National Medicines (SHSE:600511) Aren't Ideal

Apr 10
Capital Allocation Trends At China National Medicines (SHSE:600511) Aren't Ideal

China National Medicines (SHSE:600511) Could Easily Take On More Debt

Feb 28
China National Medicines (SHSE:600511) Could Easily Take On More Debt

Shareholder Returns

600511CN HealthcareCN Market
7D3.1%-1.4%-2.4%
1Y-9.8%-34.0%-20.1%

Return vs Industry: 600511 exceeded the CN Healthcare industry which returned -34% over the past year.

Return vs Market: 600511 exceeded the CN Market which returned -20.1% over the past year.

Price Volatility

Is 600511's price volatile compared to industry and market?
600511 volatility
600511 Average Weekly Movement3.8%
Healthcare Industry Average Movement4.8%
Market Average Movement5.4%
10% most volatile stocks in CN Market8.6%
10% least volatile stocks in CN Market3.6%

Stable Share Price: 600511 has not had significant price volatility in the past 3 months.

Volatility Over Time: 600511's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19993,138Guotao Tianwww.cncm.com.cn

China National Medicines Corporation Ltd., together with its subsidiaries, distributes pharmaceutical products in China. The company also manufactures and sells new drugs and finished drugs; sells Chinese patent medicines and western medicines, and medical equipment; and offers warehousing and import and export agency services. It serves hospitals, retail pharmacies, and medical institutions.

China National Medicines Corporation Ltd. Fundamentals Summary

How do China National Medicines's earnings and revenue compare to its market cap?
600511 fundamental statistics
Market capCN¥22.31b
Earnings (TTM)CN¥2.16b
Revenue (TTM)CN¥50.31b

10.3x

P/E Ratio

0.4x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
600511 income statement (TTM)
RevenueCN¥50.31b
Cost of RevenueCN¥46.43b
Gross ProfitCN¥3.88b
Other ExpensesCN¥1.72b
EarningsCN¥2.16b

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)2.87
Gross Margin7.72%
Net Profit Margin4.30%
Debt/Equity Ratio1.3%

How did 600511 perform over the long term?

See historical performance and comparison

Dividends

2.9%

Current Dividend Yield

30%

Payout Ratio